GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Liabilities-to-Assets

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Liabilities-to-Assets : 0.07 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Shenzhen New Industries Biomedical Engineering Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥610 Mil. Shenzhen New Industries Biomedical Engineering Co's Total Assets for the quarter that ended in Mar. 2024 was ¥8,575 Mil. Therefore, Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 0.07.


Shenzhen New Industries Biomedical Engineering Co Liabilities-to-Assets Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Liabilities-to-Assets Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.10 0.09 0.09 0.08

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.08 0.08 0.08 0.07

Competitive Comparison of Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets

For the Medical Devices subindustry, Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets falls into.



Shenzhen New Industries Biomedical Engineering Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=678.089/8222.489
=0.08

Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as

Liabilities-to-Assets (Q: Mar. 2024 )=Total Liabilities/Total Assets
=610.451/8574.96
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen New Industries Biomedical Engineering Co  (SZSE:300832) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Shenzhen New Industries Biomedical Engineering Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Traded in Other Exchanges
N/A
Address
No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000
Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.
Executives
Ma Jie Supervisors
Ding Chen Liu Executives
Zhang Xiao Hong Executives
Zhang Lei Directors, executives
Li Ting Hua Executives
Liu Hai Yan Executives
Song Hong Tao Supervisors
Liu Peng Director
Jiang Li Li Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines